Stay updated on Imsidolimab in Generalized Pustular Psoriasis Clinical Trial

Sign up to get notified when there's something new on the Imsidolimab in Generalized Pustular Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Imsidolimab in Generalized Pustular Psoriasis Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Page revision updated from v3.2.0 to v3.3.2; no changes to study content or data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:30:12.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The notice about government funding and potential delays has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T06:49:28.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The updates appear limited to formatting, dates, and minor UI sections; no changes to core study details or eligibility criteria are observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T20:35:39.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with an inserted government operating status notice; previous version v3.1.0 removed.
    Difference
    4%
    Check dated 2025-10-06T04:50:53.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.
    Difference
    0.1%
    Check dated 2025-09-29T02:55:19.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    New sponsor and study details added (Vanda Pharmaceuticals; a single-arm, multiple-dose study of imsidolimab for GPP with a detailed description and date references). The old sponsor/links from AnaptysBio, Inc. were removed.
    Difference
    5%
    Check dated 2025-09-21T22:25:53.000Z thumbnail image

Stay in the know with updates to Imsidolimab in Generalized Pustular Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Imsidolimab in Generalized Pustular Psoriasis Clinical Trial page.